Guggenheim Capital’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,962
Closed -$967K 1618
2025
Q2
$967K Sell
12,962
-222
-2% -$14.7K 0.01% 895
2025
Q1
$838K Sell
13,184
-229
-2% -$15.6K 0.01% 954
2024
Q4
$1.05M Sell
13,413
-412
-3% -$33.1K 0.01% 897
2024
Q3
$1.11M Sell
13,825
-135
-1% -$10.9K 0.01% 1045
2024
Q2
$1.15M Sell
13,960
-670
-5% -$58.9K 0.01% 1045
2024
Q1
$1.25M Buy
14,630
+3,446
+31% +$270K 0.01% 1089
2023
Q4
$956K Buy
11,184
+2,132
+24% +$184K 0.01% 1184
2023
Q3
$811K Buy
+9,052
New +$808K 0.01% 1199
2023
Q1
Sell
-10,459
Closed -$823K 1953
2022
Q4
$823K Sell
10,459
-1,619
-13% -$130K 0.01% 1262
2022
Q3
$894K Sell
12,078
-132
-1% -$9.48K 0.01% 1193
2022
Q2
$795K Sell
12,210
-657
-5% -$38.9K 0.01% 1337
2022
Q1
$814K Buy
12,867
+525
+4% +$28.5K ﹤0.01% 1468
2021
Q4
$655K Sell
12,342
-1,455
-11% -$88.7K ﹤0.01% 1555
2021
Q3
$974K Buy
13,797
+2,554
+23% +$161K 0.01% 1430
2021
Q2
$749K Buy
11,243
+1,894
+20% +$134K ﹤0.01% 1641
2021
Q1
$1.04M Buy
9,349
+5,675
+154% +$702K 0.01% 1378
2020
Q4
$436K Buy
+3,674
New +$396K ﹤0.01% 1689
2020
Q2
Sell
-2,359
Closed -$235K 1904
2020
Q1
$235K Sell
2,359
-872
-27% -$94.6K ﹤0.01% 1617
2019
Q4
$371K Sell
3,231
-2,456
-43% -$297K ﹤0.01% 1730
2019
Q3
$717K Buy
5,687
+1,229
+28% +$156K 0.01% 1469
2019
Q2
$536K Sell
4,458
-424
-9% -$41.7K ﹤0.01% 1624
2019
Q1
$427K Sell
4,882
-681
-12% -$61.9K ﹤0.01% 1756
2018
Q4
$557K Buy
+5,563
New +$584K ﹤0.01% 1633
2014
Q4
Sell
-5,938
Closed -$208K 3048
2014
Q3
$208K Buy
5,938
+191
+3% +$6.82K ﹤0.01% 2816
2014
Q2
$202K Sell
5,747
-426
-7% -$14.2K ﹤0.01% 2902
2014
Q1
$202K Buy
+6,173
New +$236K ﹤0.01% 2883
2013
Q4
Sell
-7,813
Closed -$312K 3213
2013
Q3
$312K Sell
7,813
-48
-0.6% -$2.01K ﹤0.01% 2592
2013
Q2
$325K Buy
+7,861
New +$318K ﹤0.01% 2586

Other funds holding HAE